Clinical Trial Update: Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating BIO89-100 in adults with biopsy-confirmed nonalcoholic steatohepatitis has completed, and the results have been posted. The trial ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• BIO89-100

Snippet

Sponsor: 89bio, Inc. | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2026-01-06